Jerini News
Most Popular Jerini Story
Shire to buy Jerini in $521M deal
With an eye toward snapping up a late-stage orphan drug for hereditary angiodema - a rare genetic disease -- Shire has agreed to pay $521 million to acquire Berlin-based Jerini AG. That's a whopping... Read more...
Latest Headlines
- October 10, 2008
- July 3, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
